Zymeworks Inc
NYSE:ZYME
Zymeworks Inc
Current Portion of Long-Term Debt
Zymeworks Inc
Current Portion of Long-Term Debt Peer Comparison
Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Zymeworks Inc
NYSE:ZYME
|
Current Portion of Long-Term Debt
$30k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Theratechnologies Inc
TSX:TH
|
Current Portion of Long-Term Debt
$12.8m
|
CAGR 3-Years
35%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Current Portion of Long-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Current Portion of Long-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Current Portion of Long-Term Debt
$13.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
168%
|
CAGR 10-Years
N/A
|
|
Spectral Medical Inc
TSX:EDT
|
Current Portion of Long-Term Debt
CA$401k
|
CAGR 3-Years
65%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
See Also
What is Zymeworks Inc's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
30k
USD
Based on the financial report for Dec 31, 2023, Zymeworks Inc's Current Portion of Long-Term Debt amounts to 30k USD.